Search

Your search keyword '"Kasprzak, Jarosław D."' showing total 879 results

Search Constraints

Start Over You searched for: Author "Kasprzak, Jarosław D." Remove constraint Author: "Kasprzak, Jarosław D."
879 results on '"Kasprzak, Jarosław D."'

Search Results

1. Multiple Phenotypes of Chronic Coronary Syndromes Identified by ABCDE Stress Echocardiography

5. Repetitive use of LEvosimendan in Ambulatory Heart Failure patients (LEIA-HF) - The rationale and study design

9. First-year follow-up costs of myocardial infarction management in Poland from the payer’s perspective

11. Baseline characteristics of Polish patients with heart failure with ejection fraction >40%: Results of HF-POL, the first study of the Heart Failure Association.

13. Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and gender differences - insights from CANT II Study

15. Functional, Anatomical, and Prognostic Correlates of Coronary Flow Velocity Reserve During Stress Echocardiography

22. Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis: An Exercise Two-Dimensional Speckle Tracking Doppler Echocardiography Study

25. The Right Heart International Network (RIGHT-NET): Rationale, Objectives, Methodology, and Clinical Implications

27. Quality control of regional wall motion analysis in stress Echo 2020

28. Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac Society

30. Clinical and electrocardiographic correlates of myocardial dysfunction after COVID‐19 in nonhospitalised patients in long‐term follow‐up. Data from the polish long‐covid cardiovascular study.

31. Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: Insights from the CANT II Study.

32. Latest findings on labetalol in severe hypertension during pregnancy and in postpartum--a systematic review.

33. Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society

37. Management of valvular heart disease in patients with cancer: Multidisciplinary team, cancer-therapy related cardiotoxicity, diagnosis, transcatheter intervention, and cardiac surgery. Expert opinion of the Association on Valvular Heart Disease, Association of Cardiovascular Interventions, and Working Group on Cardiac Surgery of the Polish Cardiac Society

39. Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial

40. Ocena i następstwa nieprawidłowej masy ciała--jak wyjaśnić paradoks otyłości?

42. The use of GLP-1 analogues in the treatment of diabetes in patients with cardiovascular diseases. The expert opinion of the Working Group of Cardiovascular Pharmacotherapy of the Polish Cardiac Society

44. Flow-mediated skin fluorescence: A novel method for the estimation of sleep apnea risk in healthy persons and cardiac patients

46. Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation

49. Quantification of the Myocardial Viability Based on Texture Parameters of Contrast Ultrasound Images

Catalog

Books, media, physical & digital resources